Retromer Therapeutics
Lead Program(s): Retromer Therapeutics is pioneering a new class of therapeutics to treat neurodegenerative diseases by restoring the function of the endolysosmal trafficking system with preclinical programs in neurodegenerative diseases.
Pre-Clinical
Phase 1
Phase 2
Phase 3